Company / Income Tax
AbCellera Biologics Inc. Income Tax History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$31.2M
FY2025
5-year range
-$37.5M / $38.9M
FY2021-FY2025
Trend
+16.9%
vs FY2024
Sector context
#195 of 204
Health Care
What the data says
Among 204 Health Care companies, AbCellera Biologics Inc. is in the top 4% for income tax. Income Tax returned to growth in FY2025 after 2 years of decline, reaching -$31M.
Based on SEC 10-K filings.
-$31M in FY2025.
Improved from -$28M to -$31M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 204This company -$31.2M Sector average $118.7M
▼
-126.3% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 16.9% year-over-year.
- Ranks #195 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$31.2M | +16.9% |
| FY2024 | -$37.5M | -35.9% |
| FY2023 | -$27.6M | -171.0% |
| FY2022 | $38.9M | +0.0% |
| FY2021 | $38.9M | +0.0% |
| FY2020 | $38.9M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026